Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe epilepsy, according to a study published online March 6 in Cureus. In a ...

Vaclav Kremen, Ph.D., Mayo Clinic researcher and co-lead author of the study The researchers monitored five patients with temporal lobe epilepsy throughout their DBS treatment. The system allowed ...

The asset, dubbed NRTX-1001, is currently being tested in an open-label phase 1/2 trial among patients with drug-resistant mesial temporal lobe epilepsy (MTLE), plus another phase 1/2 study for ...

Medial temporal lobectomy is effective in improving seizure outcomes among patients with drug-resistant temporal lobe ...